Related Experiment Video
Updated: Nov 18, 2025
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
826
Cholangiocarcinoma Therapeutics: An Update
Mai Ly Thi Nguyen1, Nguyen Linh Toan2, Maria Bozko3
1Department of Internal Medicine I, Universitätsklinikum Tübingen, Tübingen, Germany.
Current Cancer Drug Targets
|February 10, 2021
Summary
This review compares cholangiocarcinoma (CCA) treatments, finding surgery with Capecitabine effective for early stages. Targeted therapies are crucial for advanced CCA with specific genetic mutations.
Area of Science:
- Hepatobiliary Oncology
- Cancer Therapeutics
- Clinical Research
Background:
- Cholangiocarcinoma (CCA) is a prevalent hepatobiliary cancer with a poor prognosis.
- Early diagnosis is infrequent, and postoperative relapse rates are high, necessitating effective treatments for advanced and recurrent disease.
- Clarifying treatment outcomes is vital for guiding clinical decisions and developing new therapeutic strategies.
Purpose of the Study:
- To compare the treatment outcomes of various therapeutics for cholangiocarcinoma (CCA).
- To evaluate treatments based on overall survival and progression-free survival metrics.
- To provide a comparative analysis of novel targeted therapies against existing treatments.
Main Methods:
- A comprehensive review of over one hundred peer-reviewed articles on CCA treatments.
- Comparison of treatment outcomes including surgery, postoperative therapies, chemotherapies (e.g., FOFLOX), and targeted therapies (IDH1, K-RAS, FGFR inhibitors).
- Evaluation against standard first-line therapies to assess efficacy and scientific basis.
Main Results:
- Early-stage CCA requires tumor resection followed by Capecitabine; chemotherapy is an option for unresectable cases.
- Targeted therapies are recommended for inoperable CCA with specific genetic alterations (FGFR, IDH1, KRAS).
- Triplet chemotherapy regimens (e.g., S-1/Gemcitabine/Cisplatin) show promise over standard Gemcitabine/Cisplatin, with Gemcitabine plus S-1 emerging as a first-line standard for advanced/recurrent CCA.
Conclusions:
- Surgical resection followed by Capecitabine is recommended for early-stage CCA.
- Targeted therapies represent a significant advancement for specific genetic subtypes of advanced CCA.
- Further research into triplet chemotherapy regimens is warranted to confirm their superiority.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.7K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.2K
Related Concept Videos
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
02:49Cancer Therapies
9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
01:27Tumor Immunotherapy
860
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
860
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
02:18Cancer
52.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.0K